Cantargia AB (publ) (CANTA.ST)
CANTA.ST Stock Price Chart
Explore Cantargia AB (publ) interactive price chart. Choose custom timeframes to analyze CANTA.ST price movements and trends.
CANTA.ST Company Profile
Discover essential business fundamentals and corporate details for Cantargia AB (publ) (CANTA.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Mar 2015
Employees
22.00
Website
https://www.cantargia.comCEO
Damian Marron
Description
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the tumor inflammation that is driven by the Interleukin-1 system and is under phase IIa clinical trial; and CAN10, an antibody against IL1RAP for treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis, and is under preclinical trial. It is also developing CANxx antibodies against IL1RAP. The company has collaboration agreements with Patheon Biologics BV and BioWa Inc. for the manufacture and production of CAN04; and Specialized Medical Services-oncology BV for the clinical study of CAN04. Cantargia AB (publ) was founded in 2010 and is based in Lund, Sweden.
CANTA.ST Financial Timeline
Browse a chronological timeline of Cantargia AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 19 Feb 2026
Upcoming earnings on 19 Nov 2025
Earnings released on 21 Aug 2025
Earnings released on 13 May 2025
EPS came in at -kr 0.26 , while revenue for the quarter reached kr 13.60M .
Earnings released on 21 Feb 2025
EPS came in at -kr 0.21 , while revenue for the quarter reached kr 10.30M .
Earnings released on 15 Nov 2024
EPS came in at -kr 0.23 .
Earnings released on 27 Aug 2024
EPS came in at -kr 0.24 .
Earnings released on 21 May 2024
EPS came in at -kr 0.20 .
Earnings released on 22 Feb 2024
EPS came in at -kr 0.40 surpassing the estimated -kr 0.43 by +6.98%.
Earnings released on 10 Nov 2023
EPS came in at -kr 0.46 falling short of the estimated -kr 0.45 by -2.22%.
Earnings released on 22 Aug 2023
EPS came in at -kr 0.34 surpassing the estimated -kr 0.48 by +29.17%.
Earnings released on 23 May 2023
EPS came in at -kr 0.45 surpassing the estimated -kr 0.47 by +4.26%.
Earnings released on 23 Feb 2023
EPS came in at -kr 0.71 .
Earnings released on 10 Nov 2022
EPS came in at -kr 0.44 .
Earnings released on 30 Aug 2022
EPS came in at -kr 0.63 .
Stock split effective on 22 Jul 2022
Shares were split 1201 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 23 May 2022
EPS came in at -kr 0.94 .
Earnings released on 24 Feb 2022
EPS came in at -kr 0.87 .
Earnings released on 11 Nov 2021
EPS came in at -kr 0.86 .
Earnings released on 19 Aug 2021
EPS came in at -kr 0.59 .
Earnings released on 26 May 2021
EPS came in at -kr 0.60 .
Earnings released on 25 Feb 2021
EPS came in at -kr 0.47 .
Earnings released on 12 Nov 2020
EPS came in at -kr 0.36 .
CANTA.ST Stock Performance
Access detailed CANTA.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.